Neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios may not be useful markers to assess disease activity in rheumatoid arthritis-Reference-Cited by-同舟云学术

Neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios may not be useful markers to assess disease activity in rheumatoid arthritis

Published:2021-11-12 Issue:45 Volume:100 Page:e27631
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Lijuan Wang,Yuting Zhou,Chaoyang Liang,Ju Yang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference28 articles.

1. Coronary flow reserve in systemic rheumatic diseases: a systematic review and meta-analysis;Erre;Rheumatol Int,2018

2. Elevated circulating T cell subsets and cytokines expression in patients with rheumatoid arthritis;Zhou;Clin Rheumatol,2019

3. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis;Lin;Cells,2020

4. Measures in rheumatoid arthritis: are we measuring too many parameters;Chandrashekara;Int J Rheum Dis,2012

5. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force;Smolen;Ann Rheum Dis,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic accuracy of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in rheumatoid arthritis: a systematic review and meta-analysis;Clinical and Experimental Medicine;2024-09-04

2. Relationship of Complete Blood Count Derived Biomarkers With Methotrexate Resistance;Cureus;2023-12-19

3. Correlation of Hematological Indices and Acute-Phase Reactants in Rheumatoid Arthritis Patients on Disease-Modifying Antirheumatic Drugs: A Retrospective Cohort Analysis;Journal of Clinical Medicine;2023-12-11

4. Neutrophil‐to‐monocyte ratio is the better new inflammatory marker associated with rheumatoid arthritis activity;Health Science Reports;2023-08

5. The association between neutrophil-to-lymphocyte ratio and disease activity in rheumatoid arthritis;Inflammopharmacology;2023-07-07